文献速递创伤与烧伤重症综合管理与镇静镇痛

钝性创伤患者初始血清磷酸盐水平与30天死亡率的相关性

Association between the initial serum phosphate level and 30-day mortality in blunt trauma patients.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论钝性创伤患者初始高磷酸盐血症与30天死亡率独立相关,将磷酸盐加入ISS、RTS和年龄可提高预测30天死亡率的AUC至0.911。

本研究为单中心回顾性观察研究,纳入2016年1月至2017年12月在一家区域创伤中心治疗的1907例钝性创伤患者,收集人口学、初始生命体征、创伤评分及含磷酸盐的实验室指标,主要终点为30天死亡率。非存活组(71例)磷酸盐水平显著高于存活组(1836例);高磷酸盐血症组30天死亡率更高、30天ICU无天数更少、输血量更多。多因素logistic回归显示高磷酸盐血症与30天死亡率独立相关。在ISS、RTS和年龄基础上加入磷酸盐后,30天死亡率的ROC曲线下面积为0.911,仅加入ISS和RTS时AUC也升高。

要点

  • 1907例钝性创伤患者中,非存活组71例的初始磷酸盐水平显著高于存活组1836例。
  • 高磷酸盐血症组较其他组30天死亡率更高、30天ICU无天数更少、输血量更多。
  • 多因素logistic回归中,高磷酸盐血症与30天死亡率独立相关。
  • 在ISS、RTS和年龄基础上加入磷酸盐后,预测30天死亡率的AUC为0.911。
  • 仅将磷酸盐加入ISS和RTS时AUC也升高。

适用人群与场景

  • 2016年1月至2017年12月在一家区域创伤中心治疗的钝性创伤患者。

研究设计与关键结果

  • 研究类型为回顾性观察研究,纳入1907例钝性创伤患者,其中存活组1836例、非存活组71例。
  • 非存活组初始磷酸盐水平显著高于存活组。
  • 高磷酸盐血症组30天死亡率更高、30天ICU无天数更少、输血量更多。
  • 多因素logistic回归分析显示高磷酸盐血症与30天死亡率独立相关。
  • ROC曲线分析显示,在ISS、RTS和年龄基础上加入磷酸盐后,预测30天死亡率的AUC为0.911;仅将磷酸盐加入ISS和RTS时AUC也升高。

证据类型、等级与局限

  • 证据类型:回顾性观察研究;证据水平:预后研究,level III。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,在钝性创伤患者中,高磷酸盐血症与30天死亡率升高相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Studies on patients with cardiac arrest or sepsis have reported that high initial phosphate levels are associated with poor outcomes. However, no previous study has investigated the association between initial phosphate levels and outcomes in blunt trauma patients.

METHODS: This study was a retrospective observational study conducted on blunt trauma patients who had been treated at the single regional trauma center between January 2016 and December 2017. Patients' demographic data, initial vital signs, trauma scores, and laboratory parameters including phosphate levels were collected from the trauma registry. The primary outcome was set to 30-day mortality. The secondary outcomes were the total volume of blood transfused, 30-day hospital-free days, and 30-day intensive care unit-free days.

RESULTS: Of the 1,907 included patients, 1,836 were in the survival group, and 71 were in the nonsurvival group. The nonsurvival group had a significantly higher phosphate level than the survival group. Patients in the hyperphosphatemia group had a higher 30-day mortality, fewer 30-day intensive care unit-free days, and higher transfusion volume than those in the other groups. In multivariable logistic regression analysis, hyperphosphatemia was independently associated with 30-day mortality. The receiver operating characteristic curve analysis showed that the area under the curve with the inclusion of phosphate in addition to Injury Severity Score, Revised Trauma Score, and age was 0.911. Area under the curve was also increased when phosphate was simply added to Injury Severity Score and Revised Trauma Score.

CONCLUSION: In blunt trauma patients, hyperphosphatemia was associated with an increased 30-day mortality.

LEVEL OF EVIDENCE: Prognostic, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Kim DW, Jung WJ, Lee DK, et al. Association between the initial serum phosphate level and 30-day mortality in blunt trauma patients. J Trauma Acute Care Surg. 2021. PMID: 34432756. doi:10.1097/TA.0000000000003271

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。